2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Head and Neck Neoplasms
4
Stomatitis
3
Squamous Cell Carcinoma of Head and Neck
3
Laryngeal Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Squamous Intraepithelial Lesions
2
Skin Neoplasms
2
Hematologic Neoplasms
2
Dyspareunia
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Warts
1
Vulvar Neoplasms
1
Vomiting
1
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Retinoblastoma
1
Radiodermatitis
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Papillomavirus Infections
1
Papilloma
1
Pain
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Interventions
Doxorubicin
16
Zidovudine
13
Vincristine
12
Bleomycin
11
Interferon alpha-2
6
Cyclophosphamide
6
Methotrexate
5
Liposomes
5
Leucovorin
5
Dexamethasone
5
tecogalan
4
sargramostim
4
Filgrastim
4
Etoposide
4
Cytarabine
4
Ritonavir
3
Nivolumab
3
Fluorouracil
3
pomalidomide
2
liposomal doxorubicin
2
interferon alfa-n1
2
Watchful Waiting
2
Valganciclovir
2
Tumor Necrosis Factor-alpha
2
Tobacco Use Cessation Devices
2
Thalidomide
2
Surveys and Questionnaires
2
Rituximab
2
Paclitaxel
2
Observation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acquired Immunodeficiency Syndrome
×
Laser Therapy
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts